LSBio
CD9 Antibody (70-150 aa, Internal)

Western blot of CD9 antibody

CD9 Antibody (70-150 aa, Internal)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human, Mouse, Rat
Format:Liquid
See all Human CD9 antibodies →
$301.00each
Catalog Number: LS-C382578-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
CD9 antibody LS-C382578 is an unconjugated rabbit polyclonal antibody to CD9 (70-150 aa, Internal) from human. It is reactive with human, mouse and rat. Validated for ELISA, IF, IHC and WB. Cited in 1 publication.
Application
ELISA, IF, IHC, IHC-P, WB
Reactivity
Hu, Ms, Rt
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
5H9 antigen | BA2 | BA-2/p24 antigen | CD9 | CD9 antigen | CD9 antigen (p24) | DRAP-27 | MIC3 | MRP-1 | Leukocyte antigen MIC3 | Tetraspanin-29 | TSPAN29 | BTCC-1 | CD9 molecule | Motility related protein-1 | Motility-related protein | TSPAN-29
Recommended Dilution: ELISA
1:20000
Recommended Dilution: IF/ICC
1:200 - 1:1000
Recommended Dilution: IHC
1:100 - 1:300
Recommended Dilution: IHC-P
1:100 - 1:300
Recommended Dilution: WB
1:500 - 1:2000
UniProt Number
P21926
SwissProt
P21926

Target

Target
Human CD9
Antigen Species
Human
Epitope
CD9 Polyclonal Antibody detects endogenous levels of CD9 protein.
Gene Name
CD9

Antibody

Host Species
Rabbit
Clonality
Polyclonal
Isotype
IgG

Immunogen

Immunogen
Synthesized peptide derived from human CD9
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Effects of pramipexole treatment on the α-synuclein content in serum exosomes of Parkinson's disease patients. Luo HT, Zhang JP, Miao F. Experimental and therapeutic medicine. 2016;12:1373-1376. PubMed: 27588058 PMC: PMC4998109

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.